Position in SNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,363,429
-$6,056,579 QoQ
Shares Held
266,372
-26.3% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#80
of 712 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $1,560,895,629 across 16 Drug Manufacturers - General names. SNY ranks #13 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
366,026 | $439,022,601 | |
| 2 | JNJ |
Johnson & Johnson
|
1,094,399 | $277,944,514 | |
| 3 | ABBV |
AbbVie Inc.
|
990,692 | $249,297,734 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,229,081 | $157,936,908 | |
| 5 | AMGN |
Amgen Inc
|
333,544 | $120,782,953 | |
| 6 | PFE |
Pfizer Inc
|
3,183,708 | $76,663,688 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
413,202 | $52,203,940 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
883,910 | $50,930,894 |
All Filings in SNY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,363,429 | 266,372 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $17,420,008 | 361,561 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $15,430,923 | 318,426 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,338,652 | 303,785 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,692,904 | 242,039 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $12,482,881 | 225,079 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $9,604,425 | 199,138 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,910,511 | 189,320 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,129,474 | 188,159 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $8,667,761 | 178,349 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $2,567,908 | 51,637 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,424,592 | 63,844 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,306,172 | 61,339 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,868,587 | 52,712 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,448,299 | 29,905 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $701,545 | 18,452 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $929,957 | 18,588 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $964,267 | 18,782 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $869,635 | 17,358 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $824,342 | 17,099 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $897,958 | 17,052 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $655,394 | 13,251 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $865,096 | 17,804 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||